基本信息
浏览量:11
职业迁徙
个人简介
The main interests of our lab are the molecular mechanisms underlying metabolic diseases and ageing. These morbidities have a profound impact, both medically and also social and economically.
Animals typically live in close association with commensal and symbiotic microbes. Recent studies have revealed that the status of gut microbiota can influence nutrition-related syndromes such as obesity and type-2 diabetes, and perhaps ageing. However, to-date we know very little about how such interactions are regulated. The suspected role of host-microbiota interactions in human disease and regulation of metabolism is largely derived from observational studies, and it is often difficult to establish whether changes in microbiota are cause or effect of pathology. Therefore we lack understanding of how microorganisms can precisely regulate the response of key components in metabolic health and longevity. Thus, it is important to understand how these microbial communities determine human physiology, and if they can be targeted by drugs to improve human health. Of particular interest is the role of microbiota in mediating effects on drugs targeted at metabolic disease and ageing. Our lab uses a combination of model organisms including C. elegans and rodents to address these key questions.
Animals typically live in close association with commensal and symbiotic microbes. Recent studies have revealed that the status of gut microbiota can influence nutrition-related syndromes such as obesity and type-2 diabetes, and perhaps ageing. However, to-date we know very little about how such interactions are regulated. The suspected role of host-microbiota interactions in human disease and regulation of metabolism is largely derived from observational studies, and it is often difficult to establish whether changes in microbiota are cause or effect of pathology. Therefore we lack understanding of how microorganisms can precisely regulate the response of key components in metabolic health and longevity. Thus, it is important to understand how these microbial communities determine human physiology, and if they can be targeted by drugs to improve human health. Of particular interest is the role of microbiota in mediating effects on drugs targeted at metabolic disease and ageing. Our lab uses a combination of model organisms including C. elegans and rodents to address these key questions.
研究兴趣
论文共 47 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Claudia Lennicke,Ivana Bjedov,Sebastian Grönke,Katja E Menger,Andrew M James, Jorge I Castillo-Quan, Lucie A G van Leeuwen,Andrea Foley, Marcela Buricova, Jennifer Adcott, Alex Montoya, Holger B Kramer,
biorxiv(2024)
Daniel Martinez-Martinez, Tanara V. Peres, Kristin Gehling,Leonor Quintaneiro, Cecilia Cabrera, Stephen J. Cutty,Lena Best,Georgios Marinos,Johannes Zimmermann, Ayesha Safoor,Despoina Chrysostomou,Joao B. Mokochinski,
crossref(2024)
Alina Renz, Mirjam Hohner, Maximilian Breitenbach,Jonathan Josephs-Spaulding, Johanna Dürrwald,Lena Best,Victoria Dulière, Chloé Mialon,Stefanie M. Bader, Raphaël Jami,Georgios Marinos, Nantia Leonidou,
crossref(2024)
Esther Meron, Maria Thaysen,Suzanne Angeli,Adam Antebi,Nir Barzilai,Joseph A Baur,Simon Bekker-Jensen,Maria Birkisdottir,Evelyne Bischof, Jens Bruening,Anne Brunet,Abigail Buchwalter,
Alina Renz, Mirjam Hohner, Maximilian Breitenbach,Jonathan Josephs-Spaulding, Johanna Dürrwald,Lena Best, Raphaël Jami,Georgios Marinos,Filipe Cabreiro,Andreas Dräger,Michael Schindler,Christoph Kaleta
crossref(2022)
Victoria Eugenia Martinez-Miguel,Celia Lujan, Tristan Espie-Caullet,Daniel Martinez-Martinez,Saul Moore,Cassandra Backes,Suam Gonzalez,Evgeniy R Galimov,André E X Brown,Mario Halic,Kazunori Tomita,Charalampos Rallis,
Lab Animalno. 5 (2021): 127-135
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn